Futurity August 5, 2024
Georgia Tech

While most treatments for cardiac events target breaking down blood clots, researchers have found a way to prevent blood clots from even forming.

Dramatically, their drug is shown to completely knock out the formation of blood clots without increasing the risks of bleeds in vivo.

This drug is both affordable and already widely available for other uses, meaning patients could experience these benefits sooner than waiting for a completely new drug to go through FDA approval. Eventually, the drug could be used to prevent second heart attacks for high-risk patients or even primary heart attacks, strokes, and other complications caused by blood clots.

The researchers presented their findings in a paper in Arteriosclerosis, Thrombosis, and Vascular Biology.

Most existing preventive...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech, Provider
JP Morgan Annual Healthcare Conference 2025: What are the key talking points likely to be?
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
Key Trends in the Evolution of PBMs and Their Future Impact on Drug Pricing and Pharmacy Operations

Share This Article